Literature DB >> 23865943

Humoral and cell-mediated immune responses to different doses of attenuated vaccine against avian infectious bronchitis virus.

Cintia Hiromi Okino1, Antônio Carlos Alessi, Maria de Fátima Silva Montassier, Artur Jordão de Magalhães Rosa, Xiuqing Wang, Hélio José Montassier.   

Abstract

The antibody and cellular immune responses against infectious bronchitis virus (IBV) were evaluated at mucosal sites of chickens after immunization with various doses of an attenuated vaccine at 1 day of age. The correlation of these immune responses with protection of tracheal tissues was evaluated after experimental infection of these birds. Significantly reduced tracheal pathologic effects, measured according to ciliostasis and histology lesions, and reduced viral load were observed only in the full-dose vaccinated group at 5 days post-infection (dpi), while incomplete protection was observed for the subdose vaccinated groups. Moreover, birds of vaccinated groups, especially with full dose, developed higher levels of lachrymal IBV-specific IgG and IgA and increased the expression of cell-mediated immunity (CMI) genes, such as gamma interferon (IFNγ), CD8+ T cell marker, and granzyme homolog A more rapidly. In addition, these humoral and cellular immune responses evaluated at mucosal sites correlated significantly with tracheal protection against homologous IBV challenge in a vaccine dose-dependent manner. The results indicate that IgG, IgA and CD8+ T cell responses developed at mucosal sites after IBV vaccination of day-old chicks, could be taken as good correlates of protection against this virus.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23865943     DOI: 10.1089/vim.2013.0015

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  13 in total

1.  Mucosal, Cellular, and Humoral Immune Responses Induced by Different Live Infectious Bronchitis Virus Vaccination Regimes and Protection Conferred against Infectious Bronchitis Virus Q1 Strain.

Authors:  Rajesh Chhabra; Anne Forrester; Stephane Lemiere; Faez Awad; Julian Chantrey; Kannan Ganapathy
Journal:  Clin Vaccine Immunol       Date:  2015-07-22

2.  Immunological aspects of the efficiency of protectotype vaccination strategy against chicken infectious bronchitis.

Authors:  Marcin Smialek; Bartlomiej Tykalowski; Daria Dziewulska; Tomasz Stenzel; Andrzej Koncicki
Journal:  BMC Vet Res       Date:  2017-02-08       Impact factor: 2.741

3.  Early immune responses and development of pathogenesis of avian infectious bronchitis viruses with different virulence profiles.

Authors:  Cintia Hiromi Okino; Marcos Antônio Zanella Mores; Iara Maria Trevisol; Arlei Coldebella; Hélio José Montassier; Liana Brentano
Journal:  PLoS One       Date:  2017-02-15       Impact factor: 3.240

4.  Memory immune responses and protection of chickens against a nephropathogenic infectious bronchitis virus strain by combining live heterologous and inactivated homologous vaccines.

Authors:  Romeu Moreira Dos Santos; Filipe Santos Fernando; Maria de Fátima Silva Montassier; Ketherson Rodrigues Silva; Priscila Diniz Lopes; Caren Pavani; Mariana Monezi Borzi; Cintia Hiromi Okino; Helio José Montassier
Journal:  J Vet Med Sci       Date:  2019-03-12       Impact factor: 1.267

5.  Exploration of the metal coordination region of concanavalin A for its interaction with human norovirus.

Authors:  Duwoon Kim; Hee-Min Lee; Kyung-Seo Oh; Ah Young Ki; Rachael A Protzman; Dongkyun Kim; Jong-Soon Choi; Min Ji Kim; Sung Hyun Kim; Bipin Vaidya; Seung Jae Lee; Joseph Kwon
Journal:  Biomaterials       Date:  2017-03-06       Impact factor: 12.479

6.  Design and Characterization of a DNA Vaccine Based on Spike with Consensus Nucleotide Sequence against Infectious Bronchitis Virus.

Authors:  Lei Zuo; Wenjun Yan; Zhou Song; Hao Li; Xin Xie; Kui Gu; Peng Ma; Yiming Tian; Changyu Zhou; Yu Zhao; Xin Yang; Hongning Wang
Journal:  Vaccines (Basel)       Date:  2021-01-14

Review 7.  Towards Improved Use of Vaccination in the Control of Infectious Bronchitis and Newcastle Disease in Poultry: Understanding the Immunological Mechanisms.

Authors:  Anthony C Ike; Chukwuebuka M Ononugbo; Okechukwu J Obi; Chisom J Onu; Chinasa V Olovo; Sophia O Muo; Okoro S Chukwu; Eleazar E Reward; Odinakachukwu P Omeke
Journal:  Vaccines (Basel)       Date:  2021-01-04

8.  Efficacy of H120 and Ma5 avian infectious bronchitis vaccines in early challenge against QX strain.

Authors:  Vahid Karimi; Arash Ghalyanchilangeroudi; Masoud Hashemzadeh; Forough Rahimi; Mohammad Taha Zabihi Petroudi; Reza Kh Farahani; Hossein Maghsoudloo; Hamed Abdollahi
Journal:  Virusdisease       Date:  2017-12-11

9.  Field Efficacy of an Attenuated Infectious Bronchitis Variant 2 Virus Vaccine in Commercial Broiler Chickens.

Authors:  Mohamed A Elhady; Ahmed Ali; Walid H Kilany; Wael K Elfeil; Hytham Ibrahim; Ahmed Nabil; Ahmed Samir; Magdy El Sayed
Journal:  Vet Sci       Date:  2018-05-09

10.  Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken.

Authors:  Javaid Jeelani Matoo; Khalid Bashir; Ajay Kumar; Narayanan Krishnaswamy; Sohini Dey; Madhan Mohan Chellappa; Saravanan Ramakrishnan
Journal:  Microb Pathog       Date:  2018-04-07       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.